Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery

Oral P2Y₁₂ platelet receptor inhibitors are a cornerstone of reducing complications in patients with acute coronary syndromes or coronary stents. Guidelines advocate discontinuing treatment with P2Y₁₂ platelet receptor inhibitors before surgery. Cangrelor, a short-acting, reversible, intravenously a...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The Heart surgery forum 2013-04, Vol.16 (2), p.E60-E69
Hauptverfasser:	Firstenberg, Michael S, Dyke, Cornelius M, Angiolillo, Dominick J, Ramaiahm, Chandrashekar, Price, Matthew, Brtko, Miroslav, Welsby, Ian, Chandna, Harish, Holmes, David R, Voeltz, Michele, Tummala, Pradyumna, Hutyra, Martin, Manoukian, Steven V, Prats, Jayne, Todd, Meredith, Liu, Tiepu, Chronos, Nicholas, Dietrich, Markus, Montalescot, Gilles, Cannon, Louis A, Topo, Eric J
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Monophosphate - administration & dosage Adenosine Monophosphate - analogs & derivatives Administration, Oral Adult Aged Aged, 80 and over Blood Transfusion - utilization Coronary Artery Bypass - statistics & numerical data Drug Therapy, Combination - statistics & numerical data Drug-Related Side Effects and Adverse Reactions - epidemiology Female Humans Injections, Intravenous Male Middle Aged Placebo Effect Platelet Aggregation Inhibitors - administration & dosage Postoperative Hemorrhage - epidemiology Postoperative Hemorrhage - prevention & control Premedication - utilization Prevalence Purinergic P2Y Receptor Antagonists - administration & dosage Pyridines - administration & dosage Risk Assessment Treatment Outcome United States - epidemiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!